News and Features
Scientific/Clinical Member and Community Member Nominations Are Now Being Accepted for the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents
The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (or the Panel) is accepting nominations for new scientific/clinical members and a community representative. Click on each link for more details:
- Scientific/clinical members. The Panel is seeking candidates with expertise in HIV clinical research and clinical care, women’s health, or neurologic complications of HIV infection.
- Community representative. The Panel is seeking candidates with knowledge and involvement in issues related to the management of HIV-infected adults and adolescents, as evidenced by experience in HIV treatment education/advocacy or clinical/public policy initiatives related to HIV treatment.
The successful candidates will serve a 4-year term beginning May 2017, with potential for reappointment for an additional term.
The Panel is a Working Group of the Office of AIDS Research Advisory Council of the National Institutes of Health. The Panel is composed of over 40 members who are clinicians, researchers, academicians, HHS representatives, and community representatives with expertise in HIV management in the United States. The Panel meets monthly via teleconferencing and annually in a face-to-face meeting to review and critically evaluate emerging scientific data relating to antiretroviral therapy and to revise the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. The latest guideline was published on July 14, 2016, and can be found at https://aidsinfo.nih.gov/.
Panel members are not financially compensated for their time commitment.
The nomination should include a curriculum vitae (for scientific/clinical members) or a resume (for community representatives) and a letter of interest or a letter of nomination (from a colleague) with specific reference to how the nominee would contribute to the work of the Panel. Self-nomination is welcome. All supporting documents should be submitted to Alice Pau, Pharm.D. electronically (email@example.com) by no later than February 10, 2017.